Published in Hepatitis Weekly, November 6th, 1995
"At this portion of the decade we should be thinking about the year 2000," Dr. Bernard Horowitz, Melville Biologics, New York, New York, told Blood Weekly. Horowitz chaired the panel on RBCs and Platelets at the Blood Safety & Screening, held October 23-25, 1995, in Washington, D.C.
The methodologies for the viral inactivation of PCs appear acceptable; those for RBCs are showing promise, but will require substantially more work. While much work to date has successfully enabled the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.